JPRN-UMIN000050063已完成Unknown
Pharmacokinetic study by single intake of the test food (pilot study) - Pharmacokinetic study by single intake of the test food (pilot study)
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- Other
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 35years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Subjects with a serious medical history, or with a history of disorders of the digestive system, circulatory system (e.g., heart failure), endocrine system, etc. Subjects who have been judged to be inappropriate for the study by the principal investigator. 2) Subjects who have a history of gastrointestinal resection surgery, excluding appendectomy. 3) Subjects who are currently taking medication or being treated by a physician. 4) Subjects who must be scheduled to receive medical treatment or medication during the study period. 5) Subjects who plan to consume health foods or supplements other than the food under study after consent. 6) Subjects who are unable to consume the test food due to preference or allergy. Subjects who may have allergies related to the test food. 7) Heavy drinkers of alcohol and heavy smokers. 8) Subjects who have difficulty in taking blood samples. 9) Subjects who donated blood over 200mL in the past 4 weeks or over 400mL in the past 12 weeks. 10) Subjects who currently or will be participating in another clinical research study during the study period. 11) Subjects who have irregular sleep or eating habits due to night work or insomnia. 12) Subjects who are engaged in strenuous physical activity. 13) Subjects judged as unsuitable for the study by the responsible doctor for other reasons.
研究者
相似试验
进行中(未招募)
不适用
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in AdolescentsType 2 Diabetes MellitusEUCTR2014-004993-40-Outside-EU/EEAMerck & Co., Inc.35
进行中(未招募)
1 期
PK Study in Adolescents and Young Adults Treated with GlucocorticoidsMedDRA version: 18.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2012-003414-14-GBMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as19
进行中(未招募)
不适用
PK Study in Adolescents with Glucocorticoid-Induced OsteoporosisosteoporosisEUCTR2012-003414-14-Outside-EU/EEAMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as16
进行中(未招募)
1 期
PK Study in Adolescents and Young Adults Treated with GlucocorticoidsOsteoporosisEUCTR2012-003414-14-ITMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.24
进行中(未招募)
1 期
PK Study in Adolescents and Young Adults Treated with GlucocorticoidsOsteoporosisMedDRA version: 18.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2012-003414-14-FIMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as19
